Počet záznamů: 1  

Phosphonate-Titanium Dioxide Assemblies: Platform for Multimodal Diagnostic-Therapeutic Nanoprobes

  1. 1.
    SYSNO ASEP0368636
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevPhosphonate-Titanium Dioxide Assemblies: Platform for Multimodal Diagnostic-Therapeutic Nanoprobes
    Tvůrce(i) Řehoř, I. (CZ)
    Vilímová, V. (CZ)
    Jendelová, Pavla (UEM-P) RID, ORCID
    Kubíček, V. (CZ)
    Jirák, D. (CZ)
    Herynek, V. (CZ)
    Kapcalová, Miroslava (UEM-P)
    Kotek, J. (CZ)
    Černý, J. (CZ)
    Hermann, P. (CZ)
    Lukeš, I. (CZ)
    Zdroj.dok.Journal of Medicinal Chemistry. - : American Chemical Society - ISSN 0022-2623
    Roč. 54, č. 14 (2011), s. 5185-5194
    Poč.str.10 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovaMRI contrast agent ; stem-cell therapy ; Ti02 particles
    Vědní obor RIVCA - Anorganická chemie
    CEZAV0Z50390703 - UEM-P (2007-2013)
    UT WOS000292892300021
    DOI10.1021/jm200449y
    AnotaceMultimodal imaging-therapeutic nanoprobe TiO2@RhdGd was prepared and successfully used for in vitro and in vivo cell tracking as well as for killing of cancer cells in vitro. TiO2 nanoparticles were used as a core for phosphonic acid modified functionalities, responsible for contrast in MRI and optical imaging. The probe shows high 1H relaxivity and relaxivity density values. Presence of fluorescent dye allows for visualization by means of fluorescence microscopy. The applicability of the probe was studied, using mesenchymal stem cells, cancer HeLa cells, and T-lymphocytes. The probe did not exhibit toxicity in any of these systems. Labeled cells were successfully visualized in vitro by means of fluorescence microscopy and MRI. Furthermore, it was shown that the probe TiO2@RhdGd can be changed into a cancer cell killer upon UV light irradiation. The above stated results represent a valuable proof of a principle showing applicability of the probe design for diagnosis and therapy.
    PracovištěÚstav experimentální medicíny
    KontaktLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Rok sběru2012
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.